Consistent with the documented upregulated Rac1 activity in cancer [28], bioinformatics analyses showed that expression of the Rac1 effector, Pak1, is significantly upregulated in lung and breast solid tumors, relative to adjacent normal tissue, for at least a two-fold increase in all four of the databases that we analyzed. Here, RAC1 is linked to cancer.